Cancer and immunotherapy is a coexistence with a history of at least 50-60 years, but since chemotherapy and radiotherapy have been at the forefront in classical medicine for 100 years, they could not come to the fore and unfortunately could not be included in treatment protocols. After 2006, it gained the necessary importance. Studies conducted after 2006 have been revolutionary in immunotherapy and the results have accelerated the treatments.
The most important scientific development of 2013: “Cancer immunotherapy”
American “Science” magazine, the most important of the 10 most important developments of 2013, is to fight the disease by activating the body’s natural defense systems to fight cancer. chose immunotherapy, which allows the organism to do it.
In the article published in the journal, it was emphasized that many cancer experts are now convinced that this method is a turning point in cancer treatment, and that immunotherapy, which was introduced many years ago, began to bear fruit.
The immune system of cancer patients has already collapsed. cancer has emerged.
In all of them, 100% of them have insulin resistance and/or latent diabetes or diabetes. Almost all of them have extremely low vitamin D levels.
They are also banned from the sun as they receive chemotherapy, and RT, which further impairs their immune system. Also, I will not talk about the harms of chemotherapy and radiotherapy. These treatments are mandatory treatments for some aggressive tumors, it is essential to save time.
Immunotherapist should always act together with the oncologist.
Both disciplines work for the benefit of the patient and the sole purpose is to heal the patient.
Studies show that immunotherapy increases the effectiveness of chemotherapy tens of times and accelerates the response.
Contrary to what is understood, they are not opposite disciplines. They should always support each other.
It is very important to save time in immunotherapy. Chemotherapy should definitely be used to gain this time, especially in chemosensitive (chemotherapy sensitive) and very fast growing and spreading aggressive cancers such as aggressive leukemia lymphoma, small cell lung cancer.
Concurrent administration of immunotherapy during chemotherapy greatly increases the sensitivity and effectiveness of treatment. It also protects the patient from the side effects of chemotherapy and increases the patient’s quality of life.
The most important issue to be considered in cancer patients is the level of CEA. The immunotherapy dose to be given is adjusted according to the CEA level. It is understood whether he will benefit from immunotherapy. Today, however, we know that even in terminally ill patients with a CEA level of 1000 and above, immunotherapy can incredibly accelerate the treatment response and increase the patient’s comfort of life.
Intestinal flora analysis and treatment accordingly constitute the main treatment of immunotherapy, which has also been published in the journal Nature. It forms the basis of personalized treatment. All treatments should be scientific and evidence-based.
The biggest problem in patients is the deterioration of oral intake. However, the most important part of the treatment consists of oral supplements and special diets.
IV high-dose ascorbate and other supplements are adjunctive treatments that have been applied for 50 years. They are usually given for a maximum of 3 months. However, this time varies according to the patient.
It is very important to determine why patients have this disease and to treat them accordingly.
It is also beneficial to eliminate sleep disorders and correct vitamin deficiencies. Multidisciplinary benefits should also be provided from psychiatry and other branches.
Lifestyle changes in the patient provide permanent immune system improvement in the patient.
Cure (full recovery) is possible. The important thing is to make the correct diagnosis and to have enough time. It is also very important that the treatment be applied to the letter. In other words, patient compliance is the most important issue. Providing this is the most difficult part of the treatment.
The compatibility of patients and their relatives determines the success of the treatment.
